We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPRT
3151
Westport Fuel Systems
WPRT
$36.9M
$181K ﹤0.01%
13,630
+490
+4% +$11.1K
ZF
3152
DELISTED
Virtus Total Return Fund Inc.
ZF
$180K ﹤0.01%
20,800
-4,006
-16% -$37.4K
GWRS icon
3153
Global Water Resources
GWRS
$218M
$179K ﹤0.01%
17,700
PVLA
3154
Palvella Therapeutics
PVLA
$2.22B
$179K ﹤0.01%
841
+25
+3% +$7.75K
CGEN icon
3155
Compugen
CGEN
$224M
$178K ﹤0.01%
81,832
+2,375
+3% +$7.52K
ETD icon
3156
Ethan Allen Interiors
ETD
$606M
$178K ﹤0.01%
10,103
-33,293
-77% -$654K
LONE
3157
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$178K ﹤0.01%
48,900
+37,900
+345% +$263K
JSD
3158
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
$178K ﹤0.01%
12,394
-3,736
-23% -$58.7K
SMM
3159
DELISTED
Salient Midstream & MLP Fund
SMM
$176K ﹤0.01%
23,789
-873
-4% -$7.62K
BPFH
3160
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$176K ﹤0.01%
16,625
ICLN icon
3161
iShares Global Clean Energy ETF
ICLN
$2.09B
$175K ﹤0.01%
+21,208
New +$180K
RWT
3162
Redwood Trust
RWT
$588M
$175K ﹤0.01%
11,622
+3
+0% +$48
SM icon
3163
SM Energy
SM
$7.71B
$175K ﹤0.01%
11,328
-44,539
-80% -$1.03M
MNTA
3164
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$175K ﹤0.01%
15,860
-3,656
-19% -$50.9K
LFVN icon
3165
LifeVantage
LFVN
$84.5M
$174K ﹤0.01%
+13,220
New +$158K
ARI
3166
Apollo Commercial Real Estate
ARI
$879M
$173K ﹤0.01%
10,405
-38,518
-79% -$711K
PXLW icon
3167
Pixelworks
PXLW
$41.4M
$173K ﹤0.01%
4,975
-492
-9% -$22.9K
PFL
3168
PIMCO Income Strategy Fund
PFL
$390M
$172K ﹤0.01%
15,780
+4,912
+45% +$54.1K
DRRX
3169
DELISTED
DURECT Corp
DRRX
$171K ﹤0.01%
+35,350
New +$308K
LOB icon
3170
Live Oak Bancshares
LOB
$1.97B
$171K ﹤0.01%
11,539
-19,030
-62% -$367K
PHK
3171
PIMCO High Income Fund
PHK
$878M
$171K ﹤0.01%
21,364
-3,743
-15% -$30.5K
EIP
3172
DELISTED
Eaton Vance Pennsylvania Municipal Bond Fund
EIP
$171K ﹤0.01%
15,000
CELP
3173
DELISTED
Cypress Environmental Partners, L.P.
CELP
$171K ﹤0.01%
30,486
-1,777
-6% -$11.5K
BDSI
3174
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$171K ﹤0.01%
46,211
+6,000
+15% +$21.1K
CALY
3175
Callaway Golf Company
CALY
$3.04B
$169K ﹤0.01%
11,046
+1,343
+14% +$26.9K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.